TNFRSF10A and neoplasm: TRAIL is an attractive antiproliferative agent because it can induce apoptosis, mainly in tumor cells, by activating death receptors 4 and 5 (DR4 and DR5), while exhibiting minor toxicity against normal cells5,6.